Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?
Medical Research Journal · 15.01.2026 · 11
DOI: 10.5603/mrj.110313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Journal, online erschienen am 15.01.2026. Verfasst von Raman Zhdanovich und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhdanovich, R., Goshev, A., Shyshko, U., & Vrubleuskaya, V. (2026). Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?. Medical Research Journal, 11(0). https://doi.org/10.5603/mrj.110313
Vancouver
Zhdanovich R, Goshev A, Shyshko U, Vrubleuskaya V. Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?. Medical Research Journal. 2026;11(0). doi:10.5603/mrj.110313
BibTeX
@article{Zhdanovich2026,
author = {Zhdanovich, Raman and Goshev, Aleksey and Shyshko, Uladzislau and Vrubleuskaya, Volga},
title = {Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?},
journal = {Medical Research Journal},
year = {2026},
volume = {11},
number = {0},
doi = {10.5603/mrj.110313}
}
EUVIMED